Assessment of the Interest of ANI in the Non-communicating Patient in Palliative Care (ANI-CARE)

December 18, 2025 updated by: University Hospital, Lille

Comfort evaluation is one of the major challenges in the palliative care setting, particularly when it comes to non-communicative patients. ANI monitoring is a non-invasive and painless technique which evaluates the parasympathetic tone activity through heart rate variability. It has proven reliable for pain assessment during general anesthesia (GA) or for sedated critically ill patients. The parasympathetic activity seems to be a good reflect of the patient's comfort, implicating stress and anxiety.

So, the ANI could be an interesting tool to assess the comfort of non-communicating end-of-life patients.

That is why the goal of our study is to assess the interest of ANI to assess the comfort of non-communicating patients hospitalized in palliative care during a painful care by comparing the ANI measure to the CPOT scale realised by the nurses in a blind manner.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lille, France
        • Hop Cardiologique Chu Lille

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Non-communicating end-of-life patient hospitalized in palliative care

Description

Inclusion Criteria:

  • Hospitalized in palliative care Non-communicating patients (Glasgow ≤ 10)

Exclusion Criteria:

  • Non sinusal heart rate
  • Respiratory rate < 9/min
  • Treated by inotropes
  • Pace-maker
  • Patient in agonal phase
  • Opposition from the guardian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Non-communicating
Non-communicating (Glasgow ≤ 10) end-of-life patient hospitalized in palliative care (age ≥ 18 years old)
Pain measurement during care procedures in palliative care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Variation of the ANI between before the care and during the care
Time Frame: From 10 minutes before the care to 10 minutes after the care
From 10 minutes before the care to 10 minutes after the care

Secondary Outcome Measures

Outcome Measure
Time Frame
Variation of the ANI between during the care and after the care
Time Frame: From 10 minutes before the care to 10 minutes after the care
From 10 minutes before the care to 10 minutes after the care
Coefficient of correlation between the variation of the ANI and the variation of the CPOT scale between each periods.
Time Frame: From 10 minutes before the care to 10 minutes after the care
From 10 minutes before the care to 10 minutes after the care
Coefficient of correlation between the minANI and the CPOT scale for each periods
Time Frame: From 10 minutes before the care to 10 minutes after the care
From 10 minutes before the care to 10 minutes after the care
Coefficient of correlations between ANImin and CPOT values before, during, and after the painful care session
Time Frame: From 10 minutes before the care to 10 minutes after the care
From 10 minutes before the care to 10 minutes after the care
The discriminatory power of the ANI to separate the non-comfortable and the comfortable population defined by a ≤ 2 threshold on the CPOT scale
Time Frame: From 10 minutes before the care to 10 minutes after the care
From 10 minutes before the care to 10 minutes after the care

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chloe PRODHOMME, MD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 22, 2022

Primary Completion (Actual)

May 24, 2024

Study Completion (Actual)

May 24, 2024

Study Registration Dates

First Submitted

July 7, 2022

First Submitted That Met QC Criteria

July 7, 2022

First Posted (Actual)

July 12, 2022

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 18, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on ANI

Subscribe